Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

CID LISTED AMONG
“MOST INFLUENTIAL”

Clinical Infectious Diseases has been named as one of the "100 Most Influential Journals in Biology and Medicine" of the past 100 years by the Special Libraries Association. The list was compiled by the 680-plus members of SLA’s Biomedical and Life Sciences Division.

See the full list here.

Source: The DBIO 100, the 100 Most Influential Journals in Biology & Medicine over the last 100 Years

In the News

Featured in MSNBC
"Germs and flu are up; infection control is down" June 9, 2009
Trends in the Incidence of Methicillin‐Resistant Staphylococcus aureus Infection in Children’s Hospitals in the United States
Jeffrey S. Gerber, Susan E. Coffin, Sarah A. Smathers, and Theoklis E. Zaoutis
Just this week, researchers reported that the incidence of MRSA infections among children admitted to pediatric hospitals in the United States more than tripled between 2002 and 2007. Researchers at the Children’s Hospital of Philadelphia and the University of Pennsylvania found cases of MRSA jumped from 6.7 per 1,000 admissions in 2002 to 21.1 cases per 1,000 admissions in 2007, according to a study released online Monday in the journal Clinical Infectious Diseases.

Featured in Toronto Star
"Pigs, viruses and politics" May 2, 2009
Are Swine Workers in the United States at Increased Risk of Infection with Zoonotic Influenza Virus?
Kendall P. Myers, Christopher W. Olsen, Sharon F. Setterquist, Ana W. Capuano, Kelley J. Donham, Eileen L. Thacker, James A. Merchant, and Gregory C. Gray
Another study, this one published in the U.S. journal Clinical Infectious Diseases in 2006, found that workers in meat-processing plants have a greater likelihood of being infected by some version of the H1N1 flu virus than the general population (the odds of pig farmers getting the disease are significantly greater again).

Featured in Philadelphia Inquirer
"A shot in the arm for vaccines" April 19, 2009
Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection
Lisa A. Jackson and Edward N. Janoff
Every year, an estimated 915,000 people 65 and older get pneumonia, and 40 percent of them end up in hospitals, according to a 2004 paper in the journal Clinical Infectious Diseases. Pneumonia often kills older people, said Richard Stefanacci, a geriatrician at the University of the Sciences in Philadelphia.

15 January 2007

Volume 44, Number 2
Clinical Infectious Diseases 2007;44:178–185
1058-4838/2007/4402-0002$15.00
DOI: 10.1086/510392
MAJOR ARTICLE

Randomized Controlled Trial of Chlorhexidine Gluconate for Washing, Intranasal Mupirocin, and Rifampin and Doxycycline Versus No Treatment for the Eradication of Methicillin‐Resistant Staphylococcus aureus Colonization

Andrew E. Simor,1,2

Elizabeth Phillips,5

Allison McGeer,1,3

Ana Konvalinka,1

Mark Loeb,6

H. Rosalyn Devlin,1,4 and

Alex Kiss2

1University of Toronto, 2Sunnybrook Health Sciences Centre, 3Mount Sinai Hospital, and 4St. Michael’s Hospital, Toronto; 5St. Paul’s Hospital, Vancouver; and 6McMaster University, Hamilton, Canada

Background.Eradication of methicillin‐resistant Staphylococcus aureus (MRSA) carriage may reduce the risk of MRSA infection and prevent transmission of the organism to other patients.

Methods.To determine the efficacy of decolonization therapy, patients colonized with MRSA were randomized (3:1 allocation) to receive treatment (2% chlorhexidine gluconate washes and 2% mupirocin ointment intranasally, with oral rifampin and doxycycline for 7 days), or no treatment. Follow‐up samples for MRSA culture were obtained from the nares, perineum, skin lesions, and catheter exit sites monthly for up to 8 months. The primary outcome measure was detection of MRSA at 3 months of follow‐up. Univariate and multivariable analyses were performed to identify variables associated with treatment failure.

Results.Of 146 patients enrolled in the study, 112 patients (87 treated; 25 not treated) were followed up for at least 3 months. At 3 months of follow‐up, 64 (74%) of those treated had culture results negative for MRSA, compared with 8 (32%) of those not treated ( ). This difference remained significant at 8 months of follow‐up, at which time, 54% of those treated had culture results negative for MRSA ( ; , by log‐rank test). The results of the multivariable analysis indicated that having a mupirocin‐resistant isolate at baseline was associated with treatment failure (relative risk, 9.4; 95% confidence interval, 2.8–31.9; ), whereas decolonization therapy was protective (relative risk, 0.1; 95% confidence interval, 0.04–0.4; ). Mupirocin resistance emerged in only 5% of follow‐up isolates.

Conclusions.Treatment with topical mupirocin, chlorhexidine gluconate washes, oral rifampin, and doxycycline for 7 days was safe and effective in eradicating MRSA colonization in hospitalized patients for at least 3 months.

Received 24 August 2006; accepted 21 September 2006; electronically published 14 December 2006.

  • (See the editorial commentary by Bradley on pages 186–9)

Reprints or correspondence: Dr. Andrew E. Simor, Dept. of Microbiology, Sunnybrook Health Sciences Centre, B121‐2075 Bayview Ave., Toronto, Canada M4N 3M5 ().

Cited by

Leanne B Gasink, Patrick J Brennan. (2009) Isolation precautions for antibiotic-resistant bacteria in healthcare settings. Current Opinion in Infectious Diseases 22:4, 339-344
Online publication date: 1-Sep-2009.
CrossRef
Kyle J. Popovich, MD. Staphylococcus aureus: Not Always Right Under Your Nose. Infection Control and Hospital Epidemiology 0:0, 000-000
Jan Kluytmans, MD, PhD; Stephan Harbarth, MD. (2009) Editorial: Methicillin‐Resistant Staphylococcus aureus Decolonization: “Yes, We Can,” But Will It Help? •. Infection Control and Hospital Epidemiology 30:7, 633-635
Online publication date: 1-Jul-2009.
Michael W. Climo, Kent A. Sepkowitz, Gianna Zuccotti, Victoria J. Fraser, David K. Warren, Trish M. Perl, Kathleen Speck, John A. Jernigan, Jaime R. Robles, Edward S. Wong. (2009) The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: Results of a quasi-experimental multicenter trial*. Critical Care Medicine 37:6, 1858-1865
Online publication date: 1-Jul-2009.
CrossRef
M. D. Bartels, K. Kristoffersen, K. Boye, H. Westh. (2009) Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search and destroy policy. Clinical Microbiology and Infection
Online publication date: 1-Jun-2009.
CrossRef
Ana del Rio, Carlos Cervera, Asunción Moreno, Phillipe Moreillon, and José M. Miró. (2009) Patients at Risk of Complications of Staphylococcus aureus Bloodstream Infection. Clinical Infectious Diseases 48:s4, S246-S253
Online publication date: 15-May-2009.
Heidi S. M. Ammerlaan, Jan A. J. W. Kluytmans, Heiman F. L. Wertheim, Jan L. Nouwen, and Marc J. M. Bonten. (2009) Healthcare Epidemiology: Eradication of Methicillin‐Resistant Staphylococcus aureus Carriage: A Systematic Review. Clinical Infectious Diseases 48:7, 922-930
Online publication date: 1-Apr-2009.
Kevin W McConeghy, Dennis J Mikolich, Kerry L LaPlante. (2009) Agents for the Decolonization of Methicillin-Resistant Staphylococcus aureus. Pharmacotherapy 29:3, 263-280
Online publication date: 1-Apr-2009.
CrossRef
Todd C. Lee, MD; Christine Moore, ART; Janet M. Raboud, PhD; Matthew P. Muller, MD, PhD; Karen Green, MSc; Agnes Tong, MSc; Jastej Dhaliwal, MSc; Allison McGeer, MD; Mount Sinai Hospital Infection Control Team. (2009) Impact of a Mandatory Infection Control Education Program on Nosocomial Acquisition of Methicillin‐Resistant Staphylococcus aureus •. Infection Control and Hospital Epidemiology 30:3, 249-256
Online publication date: 1-Mar-2009.
Pramodini Kale-Pradhan, Leonard B Johnson. (2009) Treatment and recurrence management of staphylococcal infections: community-acquired MRSA. Expert Review of Anti-infective Therapy 6:6, 909-915
Online publication date: 1-Jan-2009.
CrossRef
Marcus Zervos. (2008) Treatment Options for Uncomplicated Community-Acquired Skin and Soft Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus : Oral Antimicrobial Agents. Surgical Infections 9:s1, s29-s34
Online publication date: 1-Nov-2008.
CrossRef
Randall G. Fisher, Rebecca L. Chain, Pamela S. Hair, Kenji M. Cunnion. (2008) HYPOCHLORITE KILLING OF COMMUNITY-ASSOCIATED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS. The Pediatric Infectious Disease Journal 27:10, 934-935
Online publication date: 1-Nov-2008.
CrossRef
A. Loeffler, S. J. Baines, M. S. Toleman, D. Felmingham, S. K. Milsom, E. A. Edwards, D. H. Lloyd. (2008) In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets. Journal of Antimicrobial Chemotherapy 62:6, 1301-1304
Online publication date: 10-Oct-2008.
CrossRef
Kyle J. Popovich, Bala Hota, Robert A. Weinstein. (2008) Treatment of community-associated methicillin-resistant Staphylococcus aureus. Current Infectious Disease Reports 10:5, 411-420
Online publication date: 1-Oct-2008.
CrossRef
D. L. Russell, A. Flood, T. E. Zaroda, C. Acosta, M. M. S. Riley, R. W. Busuttil, D. A. Pegues. (2008) Outcomes of Colonization with MRSA and VRE Among Liver Transplant Candidates and Recipients. American Journal of Transplantation 8:8, 1737-1743
Online publication date: 1-Sep-2008.
CrossRef
Rupak Datta and Susan S. Huang. (2008) Risk of Infection and Death due to Methicillin‐Resistant Staphylococcus aureus in Long‐Term Carriers. Clinical Infectious Diseases 47:2, 176-181
Online publication date: 15-Jul-2008.
Nalini Rao, Barbara Cannella, Lawrence S. Crossett, A. J. Yates, Richard McGough. (2008) A Preoperative Decolonization Protocol for Staphylococcus aureus Prevents Orthopaedic Infections. Clinical Orthopaedics and Related Research 466:6, 1343-1348
Online publication date: 1-Jul-2008.
CrossRef
By M. Buehlmann, ; R. Frei, ; L. Fenner, ; M. Dangel, ; U. Fluckiger, ; A. F. Widmer, . (2008) Highly Effective Regimen for Decolonization of Methicillin-Resistant Staphylococcus aureus Carriers. Infection Control and Hospital Epidemiology 29:6, 510-516
Online publication date: 1-Jun-2008.
Kyle J. Popovich, Bala Hota. (2008) Treatment and prevention of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Dermatologic Therapy 21:3, 167-179
Online publication date: 1-Jun-2008.
CrossRef
Susan S. Huang, Daniel J. Diekema, David K. Warren, Gianna Zuccotti, Patricia L. Winokur, Shailesh Tendolkar, Linda Boyken, Rupak Datta, Rebecca M. Jones, Melissa A. Ward, Tanya Aubrey, Andrew B. Onderdonk, Christian Garcia, and Richard Platt. (2008) Strain‐Relatedness of Methicillin‐Resistant Staphylococcus aureus Isolates Recovered from Patients with Repeated Infection. Clinical Infectious Diseases 46:8, 1241-1247
Online publication date: 15-Apr-2008.
Michelle K. Mendyk. (2008) Community-Associated MRSA. The Nurse Practitioner 33:3, 26-32
Online publication date: 1-Apr-2008.
CrossRef
C Buddy Creech, Susan E. Beekmann, YiYi Chen, Philip M. Polgreen. (2008) VARIABILITY AMONG PEDIATRIC INFECTIOUS DISEASES SPECIALISTS IN THE TREATMENT AND PREVENTION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS SKIN AND SOFT TISSUE INFECTIONS. The Pediatric Infectious Disease Journal 27:3, 270-272
Online publication date: 1-Apr-2008.
CrossRef
Jason E. Farley. (2008) Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus. Journal of the American Academy of Nurse Practitioners 20:2, 85-92
Online publication date: 1-Mar-2008.
CrossRef
Seth A. Larkin, Brian S. Murphy. (2008) Preoperative Decolonization of Methicillin-Resistant Staphylococcus aureus. Orthopedics 31:1, 37-41
Online publication date: 1-Feb-2008.
CrossRef
Jason G Newland, Gregory L Kearns. (2008) Treatment Strategies for Methicillin-Resistant Staphylococcus aureus Infections in Pediatrics. Pediatric Drugs 10:6, 367-378
Online publication date: 1-Feb-2008.
CrossRef
Aaron M. Milstone, Catherine L. Passaretti, and Trish M. Perl. (2008) Healthcare Epidemiology: Chlorhexidine: Expanding the Armamentarium for Infection Control and Prevention. Clinical Infectious Diseases 46:2, 274-281
Online publication date: 15-Jan-2008.
Michael R Jacobs. (2008) Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children. Future Microbiology 2:6, 591-600
Online publication date: 1-Jan-2008.
CrossRef
Robert A Bonomo, Peter S Van Zile, Qing Li, Kenneth M Shermock, William G McCormick, Bruce Kohut. (2007) Topical triple-antibiotic ointment as a novel therapeutic choice in wound management and infection prevention: a practical perspective. Expert Review of Anti-infective Therapy 5:5, 773-782
Online publication date: 1-Nov-2007.
CrossRef
W Charles Huskins. (2007) Interventions to prevent transmission of antimicrobial-resistant bacteria in the intensive care unit. Current Opinion in Critical Care 13:5, 572-577
Online publication date: 1-Nov-2007.
CrossRef
Joseph A. Bick. (2007) Healthcare Epidemiology: Infection Control in Jails and Prisons. Clinical Infectious Diseases 45:8, 1047-1055
Online publication date: 15-Oct-2007.
Kyle J. Popovich, Bala Hota, Robert A. Weinstein. (2007) Treatment of community-associated methicillin-resistant Staphylococcus aureus. Current Infectious Disease Reports 9:5, 398-407
Online publication date: 1-Oct-2007.
CrossRef
Brooks Gainer. (2007) Snapshot for September 2007. Infectious Diseases in Clinical Practice 15:5, 297-298
Online publication date: 1-Oct-2007.
CrossRef
Fredrick M. Abrahamian, Eric W. Snyder. (2007) Community-associated methicillin-resistant Staphylococcus aureus: Incidence, clinical presentation, and treatment decisions. Current Infectious Disease Reports 9:5, 391-397
Online publication date: 1-Oct-2007.
CrossRef
Jeffrey C. Jones, Theodore J. Rogers, Peter Brookmeyer, William Michael Dunne, Jr., Gregory A. Storch, Craig M. Coopersmith, Victoria J. Fraser, and David K. Warren. (2007) Mupirocin Resistance in Patients Colonized with Methicillin‐Resistant Staphylococcus aureus in a Surgical Intensive Care Unit. Clinical Infectious Diseases 45:5, 541-547
Online publication date: 1-Sep-2007.
C. Wendt, MD, MS; S. Schinke, MD; M. Württemberger, RN; K. Oberdorfer, MD; O. Bock‐Hensley, MD; H. von Baum, MD. (2007) Value of Whole‐Body Washing With Chlorhexidine for the Eradication of Methicillin‐Resistant Staphylococcus aureus: A Randomized, Placebo‐Controlled, Double‐Blind Clinical Trial •. Infection Control and Hospital Epidemiology 28:9, 1036-1043
Online publication date: 1-Sep-2007.
David Friedel, Michael Climo. (2007) Nasal colonization with methicillin-resistant Staphylococcus aureus: Clinical implications and treatment. Current Infectious Disease Reports 9:3, 201-207
Online publication date: 1-Jun-2007.
CrossRef
Suzanne F. Bradley. (2007) Editorial Commentary: Eradication or Decolonization of Methicillin‐Resistant Staphylococcus aureus Carriage: What Are We Doing and Why Are We Doing It?. Clinical Infectious Diseases 44:2, 186-189
Online publication date: 15-Jan-2007.
Close Popup